No Data
No Data
Express News | Illumina Shares Are Trading Lower. The Company Announced It Will Present Its Research at the ASCO Annual Meeting
Express News | Illumina To Present Latest Research At American Society Of Clinical Oncology Annual Meeting In Chicago, May 31–June 4
Immena Releases 2023 Corporate Social Responsibility Report
SAN DIEGO, Calif., May 29, 2024/PRNewswire/ -- On May 28, 2024, Immena (NASDAQ: ILMN), a global leader in genetic sequencing and chip technology, released its fifth annual corporate social responsibility (CSR) report, which highlights the company's continued commitment to patients, communities, employees, and the planet in 2023 and progress in advancing the cause of human health. “At Immena, we are committed to improving human health through the power of genes.” Inmena CEO Jacob Thaysen said, “”
Illumina Drives Genomic Testing as Standard of Care in Oncology Through Collaborative Research Presented at ASCO
Studies presented represent key focus areas, including building evidence for clinical utility of comprehensive genomic profiling; overcoming market access barriers, and progressing the whole-genome ap
Deel Elects Francis DeSouza to Its Board of Directors
deSouza brings decades of experience leading global, innovation-driven companies, both as an entrepreneur and growing large, complex companiesSAN FRANCISCO--(BUSINESS WIRE)--Deel today announced the e
Integrated Biosciences Joins Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome
Partnership combines Integrated Biosciences' pioneering research in AI/ML-enabled small molecule drug discovery and bulk and single cell sequencing offered through Illumina Ventures Labs Integrated Biosciences, a
No Data